Author:
Papadopoulos Esperanza B.,Jakubowski Ann A.
Publisher
Springer Science and Business Media LLC
Reference70 articles.
1. Champlin R, Khouri I, Anderlini P, et al.: Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation: biology and current indications. Oncology 2003, 17:94–100; discussion 103–107.
2. Grewal SS, Barker JN, Davies SM, Wagner JE: Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003, 101:4233–4244. Review article comparing marrow and umbilical cord stem cell sources. The authors explore these issues with regard to selected patient populations.
3. Aversa F, Berneman ZN, Locatelli F, et al.: Fourth international workshop on haploidentical transplants, Naples, Italy, July 8–10, 2004. Blood Cells Mol Dis 2004, 33:159–175.
4. Kernan NA: T-cell depletion for the prevention of graft-vshost disease. In Hematopoietic Cell Transplantation, edn 2. Edited by Thomas DE, Blume KG, Forman SJ. Boston: Blackwell Scientific Publications; 1999:186–196.
5. Wagner JE, Thompson JS, Carter SL, et al.: Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial. Lancet, 2005. 366(9487): 733–741. Prospective randomized trial comparing transplant outcomes after T-cell depletion or unmodified transplants from unrelated donors in patients with acute and chronic leukemias.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献